San Diego, United States
Empirico is a clinical-stage biotechnology company focused on pioneering siRNA medicines that mimic beneficial genetic variants. Their work is revolutionized by two proprietary platforms: the Precision Insights Platform™ for target discovery and the siRCH™ platform for siRNA development. These technologies enable the swift transformation of novel discoveries into viable therapeutics, meeting critical health needs.
Although the specific founding date and last investment details are not disclosed, Empirico's commitment to innovative genetic solutions positions them well for potential investor interest. The company maintains a strong base in San Diego, CA, with additional R&D operations in Madison, WI.
Empirico's growing pipeline, composed of both proprietary and collaborative programs, targets a broad spectrum of common diseases with significant unmet needs. This strategic approach, combined with robust partnerships, underlines their capacity to address complex health challenges and deliver therapeutic breakthroughs.
